Pharmaceutical company Binnopharm Group, part of Sistema, has developed and registered a linezolid substance that is used to produce Linezolid in tablet form. It is used to treat severe infectious diseases caused by Gram-positive bacteria that are resistant to other antibiotics. The first such batch of 17,000 full-cycle packages was released at the end of October this year.